Heidelberg Pharma financials at a glance

The revenue of Heidelberg Pharma is reported as 0.0138 billion Euro in the fiscal year 2023. The earnings were -0.72 Euro per share in 2023, which was 33.75 higher than 2021. And about 0 billion Euro are reported as free cash flow in the financials of Heidelberg Pharma 2023. No dividends were paid to the shareholders of the Heidelberg Pharma stock XTRA:HPHA in the financial year 2023.